Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Abstract Introduction Patients with type 2 diabetes (T2D) who require intensification of basal insulin therapy need treatment options that can improve their health-related quality of life (HRQoL) and translate into better outcomes
Semaglutide acts like a gut hormone signal, while metformin mainly reduces liver glucose output and improves insulin sensitivity
Prior GLP-1-based medication use The majority of patients (94.2%) had an encounter within the prior year and were therefore included in the switching pattern analysis
The maximum semaglutide dose for weight management is 2.4 mg weekly (Wegovy dosing)
The research team, which has had the results for only about two weeks, plans to do a deeper dive into the data and present more results at the Alzheimers and Parkinsons Diseases Conferences next year, Cummings said
